Fear of needles is stopping some people from starting treatment 13% of people who had considered using GLP-1s but decided against it said a significant fear of needles influenced their decision
REP reports consulting fees from Bayer AG, Corcept Therapeutics, Dexcom, Hanmi Pharmaceutical Co., Merck, Novo Nordisk, Pfizer, Sanofi, Scohia Pharma Inc., and Sun Pharmaceutical Industries
[2] [3] NICE guidance (NG28) recommends GLP-1 receptor agonists for adults with type 2 diabetes who have inadequate glycaemic control despite optimal management with metformin and other oral agents, particularly when significant weight loss would be beneficial
A professional can also help you navigate any dietary adjustments needed to minimize gastrointestinal side effects
While injecting degraded semaglutide is unlikely to be toxic in the traditional sense, it can cause increased injection site reactions or, more commonly, simply fail to work